Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Decramer

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|June 28, 2011
The European respiratory roadmapMarc Decramer,
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 5, 2008
Pulmonary rehabilitation 2007: from bench to practice and backMarc Decramer
Multidisciplinary Respiratory Medicine|September 11, 2012
The European respiratory roadmapMarc Decramer
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 4, 2009
Response of the respiratory muscles to rehabilitation in COPDMarc Decramer
Expert Opinion on Pharmacotherapy|March 23, 2007
Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary diseaseSteven Simoens, Marc Decramer
COPD|January 24, 2007
Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPDMarc Decramer, Gary Ferguson
The European Respiratory Journal|March 5, 2013
Who can pay for innovative medicines?Stefaan Decramer, Marc Decramer
Lancet (London, England)|December 21, 2010
European conference on chronic respiratory diseaseMarc Decramer, Yves Sibille
The Lancet. Respiratory Medicine|December 11, 2013
Chronic obstructive pulmonary disease and comorbiditiesMarc Decramer, Wim Janssens
Expert Opinion on Pharmacotherapy|June 24, 2008
A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacinSteven Simoens, Marc Decramer
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|June 28, 2011
The European respiratory roadmapMarc Decramer,
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 5, 2008
Pulmonary rehabilitation 2007: from bench to practice and backMarc Decramer
Multidisciplinary Respiratory Medicine|September 11, 2012
The European respiratory roadmapMarc Decramer
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 4, 2009
Response of the respiratory muscles to rehabilitation in COPDMarc Decramer
Expert Opinion on Pharmacotherapy|March 23, 2007
Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary diseaseSteven Simoens, Marc Decramer
COPD|January 24, 2007
Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPDMarc Decramer, Gary Ferguson
The European Respiratory Journal|March 5, 2013
Who can pay for innovative medicines?Stefaan Decramer, Marc Decramer
Lancet (London, England)|December 21, 2010
European conference on chronic respiratory diseaseMarc Decramer, Yves Sibille
The Lancet. Respiratory Medicine|December 11, 2013
Chronic obstructive pulmonary disease and comorbiditiesMarc Decramer, Wim Janssens
Expert Opinion on Pharmacotherapy|June 24, 2008
A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacinSteven Simoens, Marc Decramer
Pageof 21